Sunday, November 17, 2024
HomeTagsGenentech

Genentech

Genentech Announces Positive Data From Global Phase III Program for Crovalimab in PNH, a Rare, Life-Threatening Blood Condition

Genentech, a member of the Roche Group announced positive results from the global Phase III COMMODORE 2 study, evaluating the efficacy and safety of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics